| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404815A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 04/07/2004 | EP1404811A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404718A2 Inhibitors of memapsin 2 and use thereof |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404694A1 Nucleoside compounds in hcv |
| 04/07/2004 | EP1404693A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404675A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 04/07/2004 | EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404663A1 Eurotinone and derivatives thereof, method for the production and use of the same |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404648A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404412A1 Treatment and composition for wound healing |
| 04/07/2004 | EP1404374A1 Slc2as as modifiers of the p53 pathway and methods of use |
| 04/07/2004 | EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 04/07/2004 | EP1404366A2 Combination therapy of gamma-interferon and b cell specific antibodies |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404364A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404356A2 Cd10-activated prodrug compounds |
| 04/07/2004 | EP1404355A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404342A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1404338A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404326A2 Method of treating parkinson's disease |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |
| 04/07/2004 | EP1404316A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
| 04/07/2004 | EP1404315A1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404306A1 A coated nicotine-containing chewing gum, manufacture and use thereof |
| 04/07/2004 | EP1404305A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404268A1 Treating epidermlyosis bullosa with thymosin beta 4 |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 04/07/2004 | EP1218404A4 A binding motif of a receptor |
| 04/07/2004 | EP1151004B1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | EP1147773B1 Medicinal compositions for treating osseous lesion in multiple myeloma |
| 04/07/2004 | EP1123384B1 Use of compositions depleted of dendritic cells for improving allogeneic hematopoietic cell transplantation |
| 04/07/2004 | EP1087783B1 Use of gastrin fragments or synthetic analogs of gastrin for the manufacture of a medicament for the treatment of helicobacter pylori-associated disorders |
| 04/07/2004 | EP1001756B1 Synergistically acting compositions for selectively combating tumor tissue |
| 04/07/2004 | EP0881219B1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0559884B2 Viral recombinant vectors for expression in muscle cells |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487951A Peptides having affinity for the GP 120 viral protein and use thereof |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487938A Quinuclidine derivatives and their use as M3 antagonists |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487931A Naphthostyrils compounds |
| 04/07/2004 | CN1487928A Chemical compounds |
| 04/07/2004 | CN1487925A Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 04/07/2004 | CN1487924A Farnesyl transferase inhibitors |
| 04/07/2004 | CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 04/07/2004 | CN1487833A Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/07/2004 | CN1487832A Novel method and compositions for local treatment of Meniere's disease, tinnitus and lor hearing loss |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1487828A New film coating |
| 04/07/2004 | CN1486987A COmpound Bajisu A and its prepn and use |
| 04/07/2004 | CN1486718A Chinese medicine for delaying senility and the prepn process of the granule |
| 04/07/2004 | CN1486709A Health care Chinese medicine for computer worker and TV watcher |
| 04/07/2004 | CN1144814C Compound poultry lymphatic factor and producing process thereof |
| 04/07/2004 | CN1144806C Thienopyrimidines compound |
| 04/07/2004 | CN1144803C Chinese chestnut flower flavone compound and its extraction process |
| 04/07/2004 | CN1144800C Indolyl derivatives as 5-hydroxytryptamine medicine |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144797C Polycyclic thiazolidin-2-ylidene amines, producing process thereof and use as medicine |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144790C Telmisartan polymorphs, producing process thereof and use in prepn. of pharmaceutical composition thereof |
| 04/07/2004 | CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof |